These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25069220)

  • 21. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The physical chemical and biological features of triglycerides. The cell absorption of functionally different palmitic+oleic lipoproteins of very low and density and linoleic+linolenic lipoproteins of low density.].
    Titov VN; Amelyushkina VA; Aripovsky AV; Tibilova OA; Kaba SI; Kukharchuk VV
    Klin Lab Diagn; 2017; 62(10):580-592. PubMed ID: 30821938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of total plasma apolipoprotein B concentration in human subjects.
    Schonfeld G; Lees RS; George PK; Pfleger B
    J Clin Invest; 1974 May; 53(5):1458-67. PubMed ID: 4363408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the molecular biology of dyslipidemias.
    Ramasamy I
    Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of cholesterol esters in triglyceride transport].
    Titov VN
    Biokhimiia; 1995 Sep; 60(9):1371-81. PubMed ID: 8562646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low and very low density lipoproteins: pathogenetic and clinical significance].
    Titov VN; Vostrov IA; Kaba SI; Ameliushkina VA; Shiriaeva IuK
    Klin Med (Mosk); 2013; 91(1):20-7. PubMed ID: 23659066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The individual fatty acids of blood plasma: biological role of substrates, parameters of quantity and quality, diagnostic of atherosclerosis and atheromotosis.].
    Rozhkova TA; Aripovsky AV; Yarovaya EB; Kaminnaya VI; Kukharchuk VV; Titov VN
    Klin Lab Diagn; 2017; 62(11):655-665. PubMed ID: 30840369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH.
    Sneck M; Nguyen SD; Pihlajamaa T; Yohannes G; Riekkola ML; Milne R; Kovanen PT; Oörni K
    J Lipid Res; 2012 Sep; 53(9):1832-9. PubMed ID: 22717515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylation of apolipoprotein B is required for proper intracellular sorting and transport of cholesteroyl esters and triglycerides.
    Zhao Y; McCabe JB; Vance J; Berthiaume LG
    Mol Biol Cell; 2000 Feb; 11(2):721-34. PubMed ID: 10679026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.
    Xie Y; Nassir F; Luo J; Buhman K; Davidson NO
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G735-46. PubMed ID: 12816761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile.
    Kaneva AM; Potolitsyna NN; Bojko ER
    Arch Physiol Biochem; 2017 Feb; 123(1):16-22. PubMed ID: 27347637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of apolipoprotein B-100 in human chylomicrons.
    Lee DM; Singh S
    Biochim Biophys Acta; 1988 May; 960(2):148-56. PubMed ID: 3284592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis.
    Gianturco SH; Gotto AM; Bradley WA
    Adv Exp Med Biol; 1985; 183():47-71. PubMed ID: 4036704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [THE SPIRIT CHOLESTEROL, BIOLOGICA L ROLE AT STAGES OF PHYLOGENESIS, MECHANISMS OF INHIBITION OF SYNTHESIS OF STEROL BY STATINS, FACTORS OF PHARMACOGENOMICS AND DIAGNOSTIC SIGNIFICANCE OF CHOLESTEROL OF LIPOPROTEINS OF LOW DENSITY].
    Titov VN; Kotlovskii MY; Pokrovskii AA; Kotlovskaia OS; Osedko AV; Titova NM; Kotlovskii YV; Digaii AM
    Klin Lab Diagn; 2015 Apr; 60(4):4-13. PubMed ID: 26189285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipoproteinemia: metabolic basis and rationale for therapy.
    Grundy SM
    Am J Cardiol; 1984 Aug; 54(5):20C-26C. PubMed ID: 6089539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.